sale of subsidiary

London Stock Exchange

Roquefort Therapeutics announces proposed sale of subsidiary Oncogeni Ltd
ByNNR March 10, 2025March 10, 2025

LONDON: Roquefort Therapeutics (LSE:ROQ), a biotech company focused on developing innovative immunology and oncology medicines, has announced a term sheet agreement for the sale of its subsidiary, Oncogeni Ltd, to The Nations Trust Holding LLC. The deal is valued at…

Read More Roquefort Therapeutics announces proposed sale of subsidiary Oncogeni Ltd
London Stock Exchange

Roquefort Therapeutics signs term sheet for $10 million sale of subsidiary
ByNNR January 2, 2025January 2, 2025

LONDON: Roquefort Therapeutics (LSE:ROQ), a publicly traded biotech company, announced it has signed a term sheet for the sale of its wholly-owned subsidiary, Lyramid Pty Ltd, to Pleiades Pharma Limited. The proposed deal values Lyramid at a minimum of $10…

Read More Roquefort Therapeutics signs term sheet for $10 million sale of subsidiary